Healthcare
Quantum BioPharma Advances Multiple Sclerosis Program with Differentiated Approach
Quantum BioPharma is progressing its clinical-stage multiple sclerosis program targeting demyelination, a novel strategy distinct from immune-modulating therapies, while maintaining a diversified portfolio including consumer wellness products and sufficient capital through 2028.
Pharmacity Attracts Growth Capital from LeapFrog Investments After Turnaround
Vietnam's leading pharmacy chain Pharmacity, under TR Capital's control, has achieved profitability and secured growth capital from LeapFrog Investments, signaling strong investor interest in the country's consumer healthcare sector.
Browns' Denzel Ward Leads Cleveland Campaign Urging Residents to Act as First Responder
Cleveland Browns cornerback Denzel Ward teams up with the American Heart Association for National CPR and AED Week to encourage bystanders to perform Hands-Only CPR, aiming to close the gap where only 41% of cardiac arrest victims receive immediate help.
Browns' Denzel Ward Leads Campaign Urging Cleveland Residents to Learn Hands-Only CPR
Cleveland Browns cornerback Denzel Ward, an American Heart Association Nation of Lifesavers NFL Player Ambassador, is appearing on billboards across Cleveland to promote Hands-Only CPR during National CPR and AED Week, aiming to dispel the myth that special training is required.
Regentis Biomaterials Targets Major Gap in Knee Cartilage Repair with Off-the-Shelf Implant
Regentis Biomaterials Ltd. is advancing GelrinC, a cell-free hydrogel implant for knee cartilage repair, which could address a significant unmet need in the U.S. market where no off-the-shelf regenerative solution currently exists.
LataMed AI Corp. to Attend MEDICA 2026 in Germany as Part of Healthcare Technology Strategy
LataMed AI Corp. will attend MEDICA 2026 in Dusseldorf to evaluate technologies and build relationships for its digital healthcare platform in Latin America.
Oncotelic and Sapu Nano to Present Deciparticle Nanomedicine Platform at BIO 2026
Oncotelic Therapeutics and Sapu Nano will showcase their Deciparticle nanomedicine platform at the BIO International Convention 2026, highlighting ultra-small formulations for water-insoluble drugs and AI integration.
LakeShore Biopharma Calls Special Meeting to Vote on Going-Private Merger
LakeShore Biopharma will hold an extraordinary general meeting on June 19, 2026, to approve a merger that would take the company private, delisting its shares from the OTC Markets.
Jupiter Neurosciences Raises $2 Million in Registered Direct Offering
Jupiter Neurosciences closes a $2 million registered direct offering to fund its clinical programs targeting CNS disorders and neuroinflammation.
NeuroOne to Present New Trigeminal Nerve Ablation System and Drug Delivery Platform at ASSFN Meeting
NeuroOne Medical Technologies will showcase its recently FDA-cleared OneRF® Trigeminal Nerve Ablation System and provide updates on its investigational SEEG-Drug Delivery System at the 2026 ASSFN Biennial Meeting, highlighting advancements in neurological surgery.
Tonix Pharmaceuticals Presents Data on High Economic Burden of Fibromyalgia at ISPOR 2026
Tonix Pharmaceuticals presented real-world data at ISPOR 2026 showing that over 93% of fibromyalgia patients have comorbidities and incur substantial healthcare costs, highlighting the unmet need for effective treatments as the company prepares to launch TONMYA.
Redwood AI and Resilience Biosciences Partner to Accelerate Drug Discovery with AI
Redwood AI Corp. has entered a collaboration with Resilience Biosciences to apply AI-driven computational chemistry for faster, more efficient small-molecule drug development, particularly targeting non-opioid therapeutics.
Onco-Innovations Advances Manufacturing Scale-Up for Lead Cancer Drug Candidate ONC010
Onco-Innovations Limited reports progress in intermediate-scale manufacturing for its nanoparticle-formulated oncology candidate ONC010, moving it closer to clinical trials in Australia.
NanoViricides Proposes NV-387 for Bundibugyo Ebola Outbreak Amid Lack of Approved Treatments
NanoViricides highlights its broad-spectrum antiviral NV-387 as a potential treatment for the Bundibugyo Ebola outbreak in Africa, where no approved vaccines or therapies exist, leveraging its host-targeted mechanism and oral formulation for easier deployment.
Visory Health Promotes Two Executives to C-Suite Amid Rapid Expansion
Visory Health announces promotions of Alexandra Robertson to Chief Growth Officer and Brittney Tierce to Chief Technology Officer, signaling the company's focus on scaling access to affordable prescription drugs.
Canadian Longevity Firm AgeReverse to Launch RESURGE Supplement in U.S.
AgeReverse, an Ontario-based longevity wellness company, is expanding into the U.S. market with its flagship RESURGE supplement, which consolidates multiple longevity ingredients into a simplified daily regimen.
HeartBeam Aims to Close Critical Gap in Early Cardiac Detection with Portable ECG System
HeartBeam is developing a cable-free, portable ECG system to address pre-hospital delays in cardiac care by enabling clinical-grade data collection outside clinical settings.
Regentis Biomaterials Targets Knee Cartilage Repair Market with Off-the-Shelf Hydrogel Implant
Regentis Biomaterials advances GelrinC, a cell-free hydrogel implant for knee cartilage repair, as clinical trials progress and a new manufacturing process scales production.
Oncotelic Therapeutics Advances CNS Drug Delivery Strategy Amid BBB Breakthroughs
Oncotelic Therapeutics' $12.5M monetization of its CNS delivery system highlights growing industry focus on blood-brain barrier bypass technologies, unlocking new biotech market opportunities.
Sexual Difficulties Common in Young Cancer Survivors, Study Finds
A new doctoral study from Karolinska Institutet reveals that young adults often experience sexual problems after cancer treatment, with severity varying by cancer type and treatment intensity.
Better Heart Health Before Pandemic Linked to Lower Risk of Severe COVID-19
Adults with higher heart health scores before the pandemic were nearly half as likely to be hospitalized or die from COVID-19, according to new research in the Journal of the American Heart Association.
New Whitening Product Aims to Address Tooth Sensitivity and Gum Irritation from Peroxide-Based Systems
A new whitening system from ioTech International promises professional-strength results without the sensitivity and irritation commonly caused by peroxide-based products.
GeoVax CEO David Dodd to Discuss MVA-Based Vaccine Platforms for Broader Infectious Disease Preparedness in Tribe Public Webinar
GeoVax Labs CEO David Dodd will participate in a Tribe Public webinar on May 28, 2026, to discuss the need for platform-based vaccine technologies to address multiple viral threats like Ebola, Marburg, mpox, and hantavirus, emphasizing the limitations of single-threat preparedness.
TransCode Therapeutics Initiates Phase 2a Trial of TTX-MC138 in Colorectal Cancer Patients with Minimal Residual Disease
TransCode Therapeutics has started a Phase 2a trial evaluating TTX-MC138 in colorectal cancer patients with minimal residual disease, aiming to reduce recurrence risk in a high-risk population.
Tonix Pharmaceuticals Publishes Phase 1 TNX-1500 Data, Paving Way for Kidney Transplant Study
Tonix Pharmaceuticals announced publication of Phase 1 data for TNX-1500, an anti-CD40L monoclonal antibody, showing favorable safety and pharmacodynamics, supporting advancement to a Phase 2 kidney transplant rejection study.
VolitionRx Reports Progress in Diagnostics Pipeline, Including Feline Lymphoma Manuscript Submission Tied to $5M Milestone
VolitionRx provided a corporate update highlighting clinical and commercial progress, including a feline lymphoma manuscript submission linked to a $5 million milestone payment and licensing discussions with over a dozen global diagnostic companies.
Study Reveals Widespread Sexual Difficulties Among Young Cancer Survivors
A new study from Karolinska Institutet finds that sexual problems are common among young adults after cancer treatment, with severity varying by cancer type and treatment intensity.
Optimi Health Corp. Featured in Diamond Equity Research Initiation Report Highlighting Commercial Psychedelics Opportunity
Optimi Health Corp. (NASDAQ: OPTH) is highlighted in a Diamond Equity Research report for its role as a commercial-stage psychedelic manufacturer with GMP infrastructure, growing traction in Australia, and potential operating leverage as prescription demand scales.
Cardio Diagnostics to Present AI Cardiovascular Risk Tools at Benefits Conferences, Targeting Employer Health Plans
Cardio Diagnostics Holdings will showcase its AI-powered cardiovascular risk assessments at four national benefits conferences in June, aiming to help employers and plan administrators reduce healthcare costs and improve workforce productivity by identifying at-risk individuals earlier.
Regentis Biomaterials Targets $3 Billion U.S. Knee Cartilage Repair Market with GelrinC
Regentis Biomaterials’ GelrinC offers a potential first-in-class, off-the-shelf solution for knee cartilage repair, with Phase III trial underway and CE Mark approval in Europe.